Neurology, Vol 45, Issue 7 1364-1369, Copyright © 1995 by American Academy of Neurology

ARTICLES

Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation

B Barbiroli, P Montagna, P Cortelli, S Iotti, R Lodi, P Barboni, L Monari, E Lugaresi, C Frassineti and P Zaniol
Cattedra di Biochimica Clinica, Universita di Bologna, Italy.

In vivo phosphorus magnetic resonance spectroscopy (31P-MRS) showed defective brain and muscle energy metabolism in three affected siblings in a family with Leber's hereditary optic neuropathy (LHON) with the 11778 mtDNA mutation. We studied 14 nonaffected members of the same pedigree by 31P-MRS and molecular genetics. Nine of 14 individuals studied had the 11778 mtDNA mutation, with various degrees of heteroplasmy. A decreased brain energy reserve, as shown by low phosphocreatine content and phosphorylation potential and high [ADP], was present in eight of these nine subjects with the 11778 mutation. A low rate of postexercise phosphocreatine recovery in muscle was present in six of the nine mutated individuals. Normal MRS findings in the brain of one and the muscle of three carriers were accompanied by a low percentage of mutated mtDNA. All subjects without mutation had normal brain and muscle MRS. 31P-MRS disclosed defective bioenergetics in the brain or muscle or both of all asymptomatic carriers studied from our pedigree.

This article has been cited by other articles:

				B. Audoin, K. T. M. Fernando, J. K. Swanton, A. J. Thompson, G. T. Plant, and D. H. Miller Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis Brain, April 1, 2006; 129(4): 1031 - 1039. [Abstract] [Full Text] [PDF]

				R Lodi, V Carelli, P Cortelli, S Iotti, M L Valentino, P Barboni, F Pallotti, P Montagna, and B Barbiroli Phosphorus MR spectroscopy shows a tissue specific in vivo distribution of biochemical expression of the G3460A mutation in Leber's hereditary optic neuropathy J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 805 - 807. [Abstract] [Full Text] [PDF]

				P Y W Man, D M Turnbull, and P F Chinnery Leber hereditary optic neuropathy J. Med. Genet., March 1, 2002; 39(3): 162 - 169. [Abstract] [Full Text] [PDF]

				M Inglese, M Rovaris, S Bianchi, L L. Mantia, G L Mancardi, A Ghezzi, P Montagna, F Salvi, and M Filippi Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy J. Neurol. Neurosurg. Psychiatry, April 1, 2001; 70(4): 444 - 449. [Abstract] [Full Text] [PDF]

				P Klivenyi, E Karg, C Rozsa, R Horvath, S Komoly, I Nemeth, S Turi, and L Vecsei {alpha}-Tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 359 - 362. [Abstract] [Full Text] [PDF]

				R. Lodi, P. Montagna, P. Cortelli, S. Iotti, S. Cevoli, V. Carelli, and B. Barbiroli `Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation Brain, September 1, 2000; 123(9): 1896 - 1902. [Abstract] [Full Text] [PDF]